Thank you to everyone who came to World CDx Boston 2015
Highlights from World CDx Boston 2015 include increased focus on the role of practising physicians with companion diagnostics and precision medicines, an even brighter spotlight being shone on the patients at the heart of the industry and deeper focus on adoption, reimbursement and market access hurdles that the field is facing more and more.
Building on this for World CDx 2016, next years summit will focus more on the role of companion diagnostics in immuno-oncology, combination therapies and the adoption of these drug-CDx combinations in the market.
“World CDx was a fantastic event both in terms of the science and the networking opportunities."
- Oscar Puig, Biomarker Leader, Oncology, Roche